Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (4): 309-312.DOI: 10.3969/j.issn.1673-8640.2022.04.002

Previous Articles     Next Articles

Research progress of new tumor molecular markers in the age of precision medicine:from accurate diagnosis to precision chemotherapy

GAO Feng   

  1. Department of Clinical Laboratory,Shanghai Jiao Tong University Affiliated Sixth People's Hospital,Shanghai 200233,China
  • Received:2021-11-29 Revised:2022-03-01 Online:2022-04-30 Published:2022-06-07

Abstract:

Malignant tumors have evolved into a severe hazard to human health. Between China's tumor diagnosis and treatment and those of Europe,America and other developed countries,there is still a significant disparity. Early determination and accurate comprehensive diagnosis and treatment are essential for achieving the aim of a healthy China. However,there can be no proper therapy without an accurate diagnosis. Accurate diagnosis is based on a thorough understanding of tumor features and their evolution. The discovery of new tumor molecular features has changed tumor diagnostic and treatment concepts and strategies in the recent years,presenting a new opportunity and challenge in the area of tumor diagnosis and therapy. New tumor marker molecules are increasingly becoming more essential in clinical tumor diagnosis,recurrence,metastasis monitoring and prognosis.

Key words: New tumor marker molecule, Accurate diagnosis, Precision chemotherapy, Epigenetic plasticity, Cancer heterogeneity

CLC Number: